Analyst Insights
Featured in The Science Advisory Board: How is the pharma-AI partnership landscape changing?
By Ulrik Kristensen, PhD, The Science Advisory Board contributing writer - January 13, 2021: 2020 was a great year for artificial intelligence (AI) in drug development, where the total investment in the industry hit $9.2Â billion and many partnerships between AI specialists and the pharmaceutical industry were formed. 2021 may ...
Charles River Acquired Distributed Bio – Here’s What it Means for the AI Ecosystem
2020 was a great year for AI in drug development where the total investment in the industry hit $9.2B and many partnerships between AI specialists and the pharmaceutical industry were formed. 2021 may prove to be just as exciting, as this year’s first acquisition was already confirmed when Charles ...
Featured in Yahoo Finance: AI Drug Development Investments Accelerated in 2020
MILTON KEYNES, England, Dec. 30, 2020 / -- The market for AI in Drug Development had a record year in 2020 with $2.9B new funding and a total funding in the industry reaching $9.2B. But while the annual investment value is reaching new heights, the number of funding rounds ...
Featured in Morningstar: AI Drug Development Investments Accelerated in 2020
MILTON KEYNES, England, Dec. 30, 2020 / -- The market for AI in Drug Development had a record year in 2020 with $2.9B new funding and a total funding in the industry reaching $9.2B. But while the annual investment value is reaching new heights, the number of funding rounds ...
AI in Drug Development Investments Accelerated in 2020
The market for AI in Drug Development had a record year in 2020 with $2.9B new funding and a total funding in the industry reaching $9.2B. But while the annual investment value is reaching new heights, the number of completed funding rounds has continued its downfall. Emersion Insights has ...
